A detailed history of Schroder Investment Management Group transactions in Guardant Health, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 36,500 shares of GH stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,500
Previous 36,500 -0.0%
Holding current value
$1.3 Million
Previous $1.05 Million 20.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$21.58 - $29.5 $787,669 - $1.08 Million
36,500 New
36,500 $987,000
Q3 2022

Nov 10, 2022

BUY
$43.66 - $61.0 $683,148 - $954,467
15,647 Added 80.21%
35,154 $1.89 Million
Q2 2022

Aug 11, 2022

SELL
$28.82 - $77.35 $584,296 - $1.57 Million
-20,274 Reduced 50.96%
19,507 $787,000
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $1.52 Million - $3.16 Million
31,465 Added 378.37%
39,781 $2.64 Million
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $230,645 - $313,118
-2,600 Reduced 23.82%
8,316 $832,000
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $177,588 - $237,641
-1,798 Reduced 14.14%
10,916 $1.37 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $98,353 - $148,449
896 Added 7.58%
12,714 $1.58 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $832,239 - $1.17 Million
6,551 Added 124.38%
11,818 $1.8 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $315,673 - $429,266
3,158 Added 149.74%
5,267 $679,000
Q3 2020

Nov 13, 2020

BUY
$80.32 - $111.8 $57,509 - $80,048
716 Added 51.4%
2,109 $228,000
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $33,450 - $53,917
553 Added 65.83%
1,393 $113,000
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $16,472 - $24,777
279 Added 49.73%
840 $56,000
Q3 2019

Nov 12, 2019

BUY
$62.59 - $110.3 $35,112 - $61,878
561 New
561 $35,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.63B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.